[English] 日本語
Yorodumi Papers
- Database of articles cited by EMDB/PDB/SASBDB data -

+
Search query

Keywords
Structure methods
Author
Journal
IF

-
Structure paper

TitleStructural basis for lipid-mediated activation of G protein-coupled receptor GPR55.
Journal, issue, pagesNat Commun, Vol. 16, Issue 1, Page 1973, Year 2025
Publish dateFeb 25, 2025
AuthorsTobias Claff / Rebecca Ebenhoch / Jörg T Kley / Aniket Magarkar / Herbert Nar / Dietmar Weichert /
PubMed AbstractGPR55 is an orphan G protein-coupled receptor (GPCR) and represents a promising drug target for cancer, inflammation, and metabolic diseases. The endogenous activation of lipid GPCRs can be solely ...GPR55 is an orphan G protein-coupled receptor (GPCR) and represents a promising drug target for cancer, inflammation, and metabolic diseases. The endogenous activation of lipid GPCRs can be solely mediated by membrane components and different lipids have been proposed as endogenous activators of GPR55, such as cannabinoids and lysophosphatidylinositols. Here, we determine high-resolution cryo-electron microscopy structures of the activated GPR55 in complex with heterotrimeric G and two structurally diverse ligands: the putative endogenous agonist 1-palmitoyl-2-lysophosphatidylinositol (LPI) and the synthetic agonist ML184. These results reveal insights into ligand recognition at GPR55, G protein coupling and receptor activation. Notably, an orthosteric binding site opening towards the membrane is observed in both structures, enabling direct interaction of the agonists with membrane lipids. The structural observations are supported by mutagenesis and functional experiments employing G protein dissociation assays. These findings will be of importance for the structure-based development of drugs targeting GPR55.
External linksNat Commun / PubMed:40000629 / PubMed Central
MethodsEM (single particle)
Resolution2.51 - 3.01 Å
Structure data

EMDB-51281: Cryo-EM consensus map of the GPR55-G13-complex bound to synthetic agonist ML184
Method: EM (single particle) / Resolution: 2.64 Å

EMDB-51282: Cryo-EM GPCR focused map of the GPR55-G13-complex bound to synthetic agonist ML184
Method: EM (single particle) / Resolution: 2.77 Å

EMDB-51283: Cryo-EM G protein focused map of the GPR55-G13-complex bound to synthetic agonist ML184
Method: EM (single particle) / Resolution: 2.51 Å

EMDB-51284, PDB-9ge2:
Structure of GPR55 in complex with G13 and synthetic agonist ML184
Method: EM (single particle) / Resolution: 2.51 Å

EMDB-51285: Cryo-EM consensus map of the GPR55-G13-complex bound to lysophosphatidylinositol
Method: EM (single particle) / Resolution: 2.96 Å

EMDB-51286: Cryo-EM GPCR focused map of the GPR55-G13-complex bound to lysophosphatidylinositol.
Method: EM (single particle) / Resolution: 3.01 Å

EMDB-51287: Cryo-EM G protein focused map of the GPR55-G13-complex bound to lysophosphatidylinositol
Method: EM (single particle) / Resolution: 2.88 Å

EMDB-51288, PDB-9ge3:
Structure of GPR55 in complex with G13 and endogenous lipid agonist lysophosphatidylinositol
Method: EM (single particle) / Resolution: 2.87 Å

Chemicals

ChemComp-CLR:
CHOLESTEROL

ChemComp-HOH:
WATER

PDB-1ikt:
LIGANDED STEROL CARRIER PROTEIN TYPE 2 (SCP-2) LIKE DOMAIN OF HUMAN MULTIFUNCTIONAL ENZYME TYPE 2 (MFE-2)

ChemComp-NAG:
2-acetamido-2-deoxy-beta-D-glucopyranose

Source
  • homo sapiens (human)
  • mus musculus (house mouse)
  • aequorea victoria (jellyfish)
KeywordsMEMBRANE PROTEIN / G protein-coupled receptor / GPCR / lipid agonist / cholesterol

+
About Yorodumi Papers

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi Papers

Database of articles cited by EMDB/PDB/SASBDB data

  • Database of articles cited by EMDB, PDB, and SASBDB entries
  • Using PubMed data

Related info.:EMDB / PDB / SASBDB / Yorodumi / EMN Papers / Changes in new EM Navigator and Yorodumi

Read more